Specific criteria for diagnosing drug-induced lupus have not been formally established. However, symptoms often overlap with those of systemic lupus erythematosus (SLE). These include: muscle and ...

Current treatment options for systemic lupus erythematosus (SLE ... is being treated for a disease flare or shortly thereafter. Drugs most commonly used in this setting are antimalarials and ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus medication litifilimab. In return, Royalty Pharma will receive undisclosed ...

The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...

BACKGROUND: Statins have been increasingly associated with drug-induced autoimmune reactions, including lupus erythematosus. OBJECTIVE: To identify and determine the clinical and biological ...

Which antiarrhythmic drug can cause drug induced lupus erythematosus? Procainamide can cause drug induced systemic lupus erythematosus (SLE). Anti-histone antibodies are present in about 95% of cases.

The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes to treatment.

Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...

Significantly, chronic exposure to procainamide may cause drug-induced lupus erythematosus. Disopyramide may be used for vagally mediated AF and obstructive hypertrophic cardiomyopathy.

Specific criteria for diagnosing drug-induced lupus have not been formally established. However, symptoms often overlap with those of systemic lupus erythematosus (SLE). These include: muscle and ...

Systemic lupus erythematosus (SLE ... The heterogeneous and flaring nature of the disease makes assessment of drug efficacy in clinical trials difficult, and a lack of clarity from regulatory ...